Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institutionM. Azoulay, Bassam Abdulkarim, Luís Souhami et al.|Journal of Neuro-Oncology|2017Cited by 83
A Phase 2 Trial of Neoadjuvant Temozolomide Followed by Hypofractionated Accelerated Radiation Therapy With Concurrent and Adjuvant Temozolomide for Patients With GlioblastomaGeorge Shenouda, Bassam Abdulkarim, Luís Souhami et al.|International Journal of Radiation Oncology*Biology*Physics|2016Cited by 58
Phase II trial of concurrent sunitinib, temozolomide, and radiotherapy with adjuvant temozolomide for newly diagnosed MGMT unmethylated glioblastomaMame Daro Faye, Bassam Abdulkarim, Jacob C. Easaw et al.|Neuro-Oncology Advances|2023Cited by 5
Analysis of Prognostic Factors for Local Recurrence in Atypical MeningiomasS.I. Shakir, Marie‐Christine Guiot, A. Al Odaini et al.|International Journal of Radiation Oncology*Biology*Physics|2016Cited by 2